Challenges on the development of a dengue vaccine: a comprehensive review of the state of the art
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Challenges on the development of a dengue vaccine: a comprehensive review of the state of the art
Authors
Keywords
-
Journal
JOURNAL OF GENERAL VIROLOGY
Volume 104, Issue 3, Pages -
Publisher
Microbiology Society
Online
2023-03-02
DOI
10.1099/jgv.0.001831
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The innate immune response following multivalent dengue vaccination and implications for protection against dengue challenge
- (2022) Ruixue Hou et al. JCI Insight
- Dengue vaccine poised for roll-out but safety concerns linger
- (2022) Smriti Mallapaty NATURE
- Evaluation of the extended efficacy of the Dengvaxia vaccine against symptomatic and subclinical dengue infection
- (2021) Henrik Salje et al. NATURE MEDICINE
- Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)
- (2021) Luis Rivera et al. CLINICAL INFECTIOUS DISEASES
- Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial
- (2020) Shibadas Biswal et al. LANCET
- Comparison of purified psoralen-inactivated and formalin-inactivated dengue vaccines in mice and nonhuman primates
- (2020) Appavu K. Sundaram et al. VACCINE
- Anti-dengue Vaccines: From Development to Clinical Trials
- (2020) Josilene Ramos Pinheiro-Michelsen et al. Frontiers in Immunology
- Modified mRNA-LNP vaccines confer protection against experimental DENV-2 infection in mice
- (2020) Mengling Zhang et al. Molecular Therapy-Methods & Clinical Development
- Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection
- (2020) Rohan Narayan et al. Frontiers in Cellular and Infection Microbiology
- Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination
- (2020) Eduardo López-Medina et al. JOURNAL OF INFECTIOUS DISEASES
- Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines
- (2019) Maria Beatriz Borges et al. PLoS Pathogens
- Assessing the Diversity and Stability of Cellular Immunity Generated in Response to the Candidate Live-Attenuated Dengue Virus Vaccine TAK-003
- (2019) Adam T. Waickman et al. Frontiers in Immunology
- Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents
- (2019) Shibadas Biswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase I Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico
- (2018) Clemente Diaz et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial
- (2018) Janine R. Danko et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice
- (2018) Viswanathan Ramasamy et al. PLoS Neglected Tropical Diseases
- Safety and Immunogenicity of a Tetravalent Live-attenuated Dengue Vaccine in Flavivirus Naive Children
- (2018) Sriluck Simasathien et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-Naïve adults
- (2018) Susan B. Manoff et al. Human Vaccines & Immunotherapeutics
- Current Status of Dengue Therapeutics Research and Development
- (2017) Jenny G. H. Low et al. JOURNAL OF INFECTIOUS DISEASES
- Collateral Damage during Dengue Virus Infection: Making Sense of DNA by cGAS
- (2017) Sebastian Aguirre et al. JOURNAL OF VIROLOGY
- Antibody-dependent enhancement of severe dengue disease in humans
- (2017) Leah C. Katzelnick et al. SCIENCE
- Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age
- (2017) Scott B. Halstead VACCINE
- Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection
- (2017) Sebastian Aguirre et al. Nature Microbiology
- The risks behind Dengvaxia recommendation
- (2016) Maíra Aguiar et al. LANCET INFECTIOUS DISEASES
- The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model
- (2016) Beth D. Kirkpatrick et al. Science Translational Medicine
- Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccinees
- (2016) Sumathy Velumani et al. Human Vaccines & Immunotherapeutics
- Vaccines and immunization strategies for dengue prevention
- (2016) Yang Liu et al. Emerging Microbes & Infections
- Dengue Fever: Causes, Complications, and Vaccine Strategies
- (2016) Niyati Khetarpal et al. Journal of Immunology Research
- Cytotoxic CD4 T Cells: Differentiation, Function, and Application to Dengue Virus Infection
- (2016) Yuan Tian et al. Frontiers in Immunology
- An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques
- (2015) Stefan Fernandez et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico
- (2015) Kristen Bauer et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
- (2015) Stephen S. Whitehead Expert Review of Vaccines
- Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
- (2015) Beth D. Kirkpatrick et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of a Rederived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults Living in Thailand: A Randomized Trial
- (2014) Veerachai Watanaveeradej et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- The Human CD8+T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved Epitopes
- (2014) Daniela Weiskopf et al. JOURNAL OF VIROLOGY
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- The dengue virus non-structural 1 protein: Risks and benefits
- (2014) Jaime Henrique Amorim et al. VIRUS RESEARCH
- A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial
- (2013) Anna P. Durbin et al. JOURNAL OF INFECTIOUS DISEASES
- A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults
- (2012) Stephen J. Thomas et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Flaviviruses and flavivirus vaccines
- (2012) Franz X. Heinz et al. VACCINE
- A dengue DNA vaccine formulated with Vaxfectin®is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbits
- (2012) Kanakatte Raviprakash et al. Human Vaccines & Immunotherapeutics
- DENV Inhibits Type I IFN Production in Infected Cells by Cleaving Human STING
- (2012) Sebastian Aguirre et al. PLoS Pathogens
- Development of sanofi pasteur tetravalent dengue vaccine
- (2011) Bruno Guy et al. Human vaccines & immunotherapeutics
- Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine
- (2011) Anna P. Durbin et al. VACCINE
- The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease
- (2011) Beth-Ann G. Coller et al. VACCINE
- From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine
- (2011) Bruno Guy et al. VACCINE
- Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine
- (2011) Kevin R. Porter et al. VACCINE
- Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults
- (2010) Wellington Sun et al. Human vaccines & immunotherapeutics
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
- (2010) W. Dejnirattisai et al. SCIENCE
- A Non Mouse-Adapted Dengue Virus Strain as a New Model of Severe Dengue Infection in AG129 Mice
- (2010) Grace K. Tan et al. PLoS Neglected Tropical Diseases
- A Protective Role for Dengue Virus-Specific CD8+ T Cells
- (2009) L. E. Yauch et al. JOURNAL OF IMMUNOLOGY
- Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy
- (2009) Monika Simmons et al. VIROLOGY
- Scientific consultation on cell mediated immunity (CMI) in dengue and dengue vaccine development
- (2008) Stephen J. Thomas et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started